Inside informationEnglish
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 22/05/2025, 01:15
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 118215_20250521